🔎 Trials Near Me

Home › Mesothelioma › Texas

Pag-aaral pangklinika para sa Mesothelioma sa Texas

20 pag-aaral para sa Mesothelioma ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • START Dallas Fort Worth, Fort Worth
  • MD Anderson, Houston
  • NEXT Oncology Houston, Houston
  • at 1 pa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07705334

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

  • NEXT Oncology - Austin, Austin
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06566079

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

  • The University of Texas MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04969315

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05732831

SW-682 in Advanced Solid Tumors

  • Mary Crowley Research Center US Oncology, Dallas
  • U.T. MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06251310

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  • Ut Southwestern, Dallas
  • Texas Oncology - DFW, Fort Worth
  • MDACC, Houston
  • at 2 pa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05245500

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Texas Oncology, Abilene
  • Texas Oncology - Central / South Texas, Austin
  • Mary Crowley Cancer Research, Dallas
  • at 3 pa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Oncology Houston, Houston
  • NEXT Oncology Dallas, Irving
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT05873686

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1/2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06710756

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

  • MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT05568680

CT-95 in Advanced Cancers Associated With Mesothelin Expression

  • Context Investigational Site, San Antonio
  • Context Investigational Site, San Antonio
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT06756035

A 2-part Phase 1/2 Open-label Trial on ODM-212

  • NEXT Oncology, Irving
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update May 4, 2026 · NCT07563738

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

  • MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06362369

A Study of VET3-TGI in Patients With Solid Tumors

  • Mary Crowley Cancer Research, Dallas
  • University of Texas MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT06444815

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

  • MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT04665206

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • The University of Texas MD Anderson Cancer Center (site 127), Houston
Nagre-recruitPhase 1/2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT03556228

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

  • Baylor St Lukes, Houston
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2025 · NCT05932199

A Study of NX-1607 in Adults With Advanced Malignancies

  • MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT05107674

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

  • MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 9, 2024 · NCT06452160

Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.